GenMark Diagnostics Reports First Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
GenMark Diagnostics (GNMK) Tops Q1 EPS by 1c
May 1, 2018 5:40 PM EDTGenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $17.25 million.
GenMark is reconfirming prior 2018 revenue guidance of $68 to $72 million. Gross margin is expected... More
